Target intelligence / Profile preview

Mitochondrial cytochrome bc1 complex (Complex III)

Target
Complex III
Molecular classification
Enzyme, Electron transport chain component
01

Overview

Mitochondrial cytochrome bc1 complex (Complex III) is a multi-subunit enzyme embedded in the inner mitochondrial membrane. It serves as a central component of the electron transport chain by transferring electrons from ubiquinol (reduced coenzyme Q) to cytochrome c while simultaneously pumping protons across the membrane. This process contributes to the electrochemical gradient that drives ATP synthesis via oxidative phosphorylation. The core catalytic subunits include cytochromes b and c1 and an iron-sulfur protein. The activity of Complex III is essential for efficient energy production in eukaryotic cells, but it also generates reactive oxygen species as a byproduct, which can contribute both to physiological signaling and pathological damage if dysregulated. Dysfunction or inhibition of this complex impairs cellular respiration and has been implicated in various diseases including inherited mitochondrial disorders, neurodegeneration, cardiovascular conditions, cancer metabolism alterations, and fibrotic diseases[1][3][5][7].

Other names
Cytochrome bc1 complexCoenzyme Q-cytochrome c reductaseUbiquinol-cytochrome c oxidoreductaseRespiratory chain complex III
02

Mechanism of action

Inhibition of electron transfer, leading to disruption of ATP production and increased ROS formation[3]

03

Biological functions

Oxidative phosphorylationATP synthesis (via proton gradient generation)Electron transfer from ubiquinol to cytochrome cReactive oxygen species (ROS) generation
04

Disease associations

Mitochondrial diseases (e.g., mitochondrial myopathies)Neurodegenerative diseaseCardiovascular diseaseCancer (through altered metabolism and ROS signaling)Pulmonary fibrosis[6]
05

Safety considerations

Inhibition leads to impaired cellular energy production, lactic acidosis, cell death.Increased ROS can cause oxidative damage.Systemic inhibition is toxic due to essential role in all aerobic cells.
06

Interacting drugs

Antimycin A

1 more in the full profile.

Beyond the preview

Go deeper on Mitochondrial cytochrome bc1 complex (Complex III).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial cytochrome bc1 complex (Complex III).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call